KWM
STLN

Kanen Wealth Management’s Starling Oncology STLN Stock Holding History

Kanen Wealth Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,777,858
Closed -$8.53M – 43
2026
Q1 		$8.53M Sell
2,777,858
-198,286
-7% -$608K 3.07% 9
2025
Q4 		$10.7M Buy
2,976,144
+1,134,043
+62% +$4.21M 3.25% 7
2025
Q3 		$6.42M Buy
+1,842,101
New +$6.31M 2.15% 11

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Kanen Wealth Management's STLN Position: Q2 2026 in Review

Kanen Wealth Management sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 2,777,858 shares — an estimated $8.53M sold.

Kanen Wealth Management first reported a position in STLN in Q3 2025 and held it in 3 quarters. The position peaked at $10.7M in Q4 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Kanen Wealth Management reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • Kanen Wealth Management sold 2,777,858 Starling Oncology shares in Q2 2026, an estimated $8.53M.
  • Kanen Wealth Management first reported a position in Starling Oncology in Q3 2025 and held it in 3 quarters.
  • Kanen Wealth Management's Starling Oncology position peaked at $10.7M in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Kanen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.